Does Aarogyasri Cover — Immunotherapy for Skin Cancer?

Melanoma is a form of skin cancer covered under Aarogyasri's broader cancer packages, but immunotherapy drugs are approved diagnosis by diagnosis, not for cancer in general. A drug listed for another cancer type isn't automatically approved for melanoma. Ask your CION oncologist's Aarogyasri desk to check the current package list against your exact diagnosis and the drug your tumour board has recommended, and get the answer in writing before you plan your finances around it either way.

Aarogyasri usually sanctions a set number of cycles upfront rather than the entire course at once. If your case needs more cycles than were approved, the hospital has to submit a fresh request with updated medical justification before continuing. This means a family can start immunotherapy under the scheme and still face a point where further cycles need re-approval, private insurance, or EMI. Ask your hospital's Aarogyasri desk how many cycles are sanctioned before treatment begins, not after.

You can ask the empanelled hospital to file a grievance or reconsideration request with the Aarogyasri Health Care Trust, backed by your tumour board's medical justification. This process takes time and isn't guaranteed to succeed. While it's pending, it's worth checking in parallel whether CGHS, ESI, or private insurance apply to your family, and asking the hospital's financial counsellor about EMI options, so treatment doesn't have to wait on the appeal's outcome.

Yes, skin cancer falls under Aarogyasri's general cancer care packages, which can cover surgery, chemotherapy, and radiotherapy at empanelled hospitals. Immunotherapy is a newer and costlier category of drugs, so its coverage for skin cancer specifically is checked separately and isn't guaranteed just because other skin cancer treatments are covered. Confirm with your hospital's Aarogyasri desk whether the exact immunotherapy drug your tumour board recommends is currently on the approved list for your diagnosis.

Aarogyasri won't pay twice for the same approved package, but if it covers only part of your course, the remaining cycles can often be funded through private insurance, reimbursement claims, or an EMI plan arranged with the hospital. Many families combine a partial Aarogyasri approval with one of these to complete the recommended course. Ask the hospital's financial counsellor to map out exactly what's covered and what the family would need to fund separately.

Your tumour board recommends the treatment; the empanelled hospital's Aarogyasri desk then submits the request with medical justification; and the Aarogyasri Health Care Trust's own medical reviewers make the final approval decision. The family isn't expected to negotiate directly with the trust, but you can and should ask the hospital for a clear status update at each stage, instead of waiting to be told only the final outcome.